Heat Biologics to Present Poster at 2017 ASCO Annual Meeting

May 30, 2017

Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017

May 11, 2017

Heat Biologics Announces Completion of Acquisition of Pelican Therapeutics

May 1, 2017

Heat Biologics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co.

Apr 26, 2017

Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting

Apr 5, 2017

Heat Biologics Reports Fiscal Year 2016 Financial Results

Mar 31, 2017

Heat Biologics Closes Public Offering of 5,000,000 Shares of Common Stock

Mar 28, 2017

Heat Biologics Prices Offering of 5,000,000 Shares of Common Stock

Mar 23, 2017

Heat Biologics Announces Proposed Public Offering of Common Stock

Mar 22, 2017

Heat Biologics Reports Positive Interim Phase 2 Lung Cancer Results in Patients Treated with HS-110 in Combination with a Checkpoint Inhibitor

Mar 21, 2017